Report Detail
Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Opportunities and Forecast 2022-2028
- RnM4401113 |
- 22 March, 2022 |
- Global |
- 139 Pages |
- GRD Survey |
- Pharma & Healthcare
This report provides a comprehensive analysis of current global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario. This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.
According to this survey, the global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) market is estimated at $ million in 2021, and projected to grow at a CAGR of % to $ million by 2028.
Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Opportunties and Forecast 2022-2028 report makes a brilliant attempt to unveil key opportunities available in the global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.
The Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market has been exhibited in detail in the following chapters
Chapter 1 displays the basic product introduction and market overview.
Chapter 2 provides the competition landscape of global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) industry.
Chapter 3 provides the market analysis by type and by region
Chapter 4 provides the market analysis by application and by region
Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
Chapter 12 provides the market forecast by type and by application
Chapter 13 provides the market forecast by region
Chapter 14 profiles global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
Chapter 15 conclusions
Segmented by Type
Serotype 6B
7F Serotype
Serotype 19A
19F Serotype
23F Serotype
24F Serotype
Segmented by Application
Infants from 6 Weeks to 15 Months Old
Children Aged 15 Months to 5 Years
Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia
Key manufacturers included in this survey
Lanzhou Biological Preparations Institute
Kexing Bio
Cansino Bio
Table of Contents
1 Product Introduction and Overview
- 1.1 Product Definition
- 1.2 Product Specification
- 1.3 Global Market Overview
- 1.3.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Status and Forecast (2017-2028)
- 1.3.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Value CAGR by Region
- 1.4 Market Drivers, Inhibitors
- 1.4.1 Market Drivers
- 1.4.2 Market Inhibitors
- 1.4.3 COVID-19 Impact Analysis
2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Supply by Company
- 2.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Volume by Company
- 2.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Value by Company
- 2.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price by Company
- 2.4 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Production Location and Sales Area of Main Manufacturers
- 2.5 Trend of Concentration Rate
3 Global and Regional 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Status by Type
- 3.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Type Introduction
- 3.1.1 Serotype 6B
- 3.1.2 7F Serotype
- 3.1.3 Serotype 9V
- 3.1.4 14 Serotype
- 3.1.5 Serotype 18C
- 3.1.6 Serotype 19A
- 3.1.7 19F Serotype
- 3.1.8 23F Serotype
- 3.1.9 24F Serotype
- 3.1.10 Other
- 3.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market by Type
- 3.2.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Volume by Type (2017-2022)
- 3.2.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Value by Type (2017-2022)
- 3.2.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price by Type (2017-2022)
- 3.3 North America: by Type
- 3.4 Europe: by Type
- 3.5 Asia Pacific: by Type
- 3.6 Central & South America: by Type
- 3.7 Middle East & Africa: by Type
4 Global and Regional 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Status by Application
- 4.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Segment by Application
- 4.1.1 Infants from 6 Weeks to 15 Months Old
- 4.1.2 Children Aged 15 Months to 5 Years
- 4.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market by Application
- 4.2.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Volume by Application (2017-2022)
- 4.2.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Value by Application (2017-2022)
- 4.2.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price by Application (2017-2022)
- 4.3 North America: by Application
- 4.4 Europe: by Application
- 4.5 Asia Pacific: by Application
- 4.6 Central & South America: by Application
- 4.7 Middle East & Africa: by Application
5 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Status by Region
- 5.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market by Region
- 5.1.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Volume by Region
- 5.1.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Value by Region
- 5.2 North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Status
- 5.3 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Status
- 5.4 Asia Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Status
- 5.5 Central & South America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Status
- 5.6 Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Status
6 North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Status
- 6.1 North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market by Country
- 6.1.1 North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Volume by Country (2017-2022)
- 6.1.2 North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Value by Country (2017-2022)
- 6.2 United States
- 6.3 Canada
- 6.4 Mexico
7 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Status
- 7.1 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market by Country
- 7.1.1 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Volume by Country (2017-2022)
- 7.1.2 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Value by Country (2017-2022)
- 7.2 Germany
- 7.3 France
- 7.4 UK
- 7.5 Italy
- 7.6 Russia
- 7.7 Spain
8 Asia Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Status
- 8.1 Asia Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market by Country
- 8.1.1 Asia Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Volume by Country (2017-2022)
- 8.1.2 Asia Pacific 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Value by Country (2017-2022)
- 8.2 China
- 8.3 Japan
- 8.4 Korea
- 8.5 Southeast Asia
- 8.6 India
- 8.7 Australasia
9 Central & South America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Status
- 9.1 Central & South America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market by Country
- 9.1.1 Central & South America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Volume by Country (2017-2022)
- 9.1.2 Central & South America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Value by Country (2017-2022)
- 9.2 Brazil
- 9.3 Argentina
- 9.4 Colombia
10 Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Status
- 10.1 Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market by Country
- 10.1.1 Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Volume by Country (2017-2022)
- 10.1.2 Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Value by Country (2017-2022)
- 10.2 Iran
- 10.3 Israel
- 10.4 Turkey
- 10.5 South Africa
- 10.8 Saudi Arabia
11 Supply Chain and Manufacturing Cost Analysis
- 11.1 Supply Chain Analysis
- 11.2 Production Process Chart Analysis
- 11.3 Raw Materials and Key Suppliers Analysis
- 11.3.1 Raw Materials Introduction
- 11.3.2 Raw Materials Key Suppliers List
- 11.4 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Manufacturing Cost Analysis
- 11.5 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Channel and Distributors Analysis
- 11.5.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Channel
- 11.5.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Distributors
- 11.6 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Downstream Major Buyers
12 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Forecast by Type and by Application
- 12.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Volume and Sales Value Forecast (2023-2028)
- 12.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Forecast by Type
- 12.2.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Volume Forecast by Type
- 12.2.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Value Forecast by Type
- 12.2.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price Forecast by Type
- 12.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Forecast by Application
- 12.3.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Volume Forecast by Application
- 12.3.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Value Forecast by Application
- 12.3.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Price Forecast by Application
13 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Forecast by Region/Country
- 13.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Forecast by Region (2023-2028)
- 13.1.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Volume Forecast by Region (2023-2028)
- 13.1.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Value Forecast by Region (2023-2028)
- 13.2 North America Market Forecast
- 13.3 Europe Market Forecast
- 13.4 Asia Pacific Market Forecast
- 13.5 Central & South America Market Forecast
- 13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
- 14.1 Pfizer
- 14.1.1 Company Information
- 14.1.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Introduction
- 14.1.3 Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
- 14.1.4 SWOT Analysis
- 14.2 Minhai Bio
- 14.2.1 Company Information
- 14.2.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Introduction
- 14.2.3 Minhai Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
- 14.2.4 SWOT Analysis
- 14.3 Lanzhou Biological Preparations Institute
- 14.3.1 Company Information
- 14.3.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Introduction
- 14.3.3 Lanzhou Biological Preparations Institute 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
- 14.3.4 SWOT Analysis
- 14.4 Kexing Bio
- 14.4.1 Company Information
- 14.4.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Introduction
- 14.4.3 Kexing Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
- 14.4.4 SWOT Analysis
- 14.5 Cansino Bio
- 14.5.1 Company Information
- 14.5.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Product Introduction
- 14.5.3 Cansino Bio 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
- 14.5.4 SWOT Analysis
...
15 Conclusion
16 Methodology
Summary:
Get latest Market Research Reports on 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13). Industry analysis & Market Report on 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) is a syndicated market report, published as Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) Market Opportunities and Forecast 2022-2028. It is complete Research Study and Industry Analysis of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV13) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
